Company intelligence / Profile preview

Konsyl Pharmaceuticals

Easton, Maryland, United States

Ownership: Private
Employees: ~41
Development stage: Other

Overview

Konsyl Pharmaceuticals commercially markets natural fiber supplements (primarily psyllium husk powder and blends), which are OTC products for digestive health and constipation, with recognized benefits in glycemic control and cholesterol management but are not considered prescription therapeutics or subject to clinical trial stages

Therapeutic areas: EndocrinologyMetabolic DisordersCardiovascularGastroenterology
Modalities: Natural productPlant-derived fiber supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Konsyl Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Konsyl Pharmaceuticals.

Explore the full profile